Keywords
Letter to the Editor
To the EditorWe read with interest the article by Olcay et al. evaluating the diagnostic and prognostic value of the blood urea nitrogen (BUN)/albumin (B/A) and BUN/creatinine (B/Cr) ratios in patients presenting with gastrointestinal bleeding.1 We would like to highlight an important methodological consideration regarding the interpretation of the B/A ratio in patients with cirrhosis.
Serum albumin is strongly influenced by hepatic synthetic function, and patients with cirrhosis frequently have reduced baseline albumin levels independent of the severity of an acute bleeding episode.2 Consequently, an elevated B/A ratio in these patients may partly reflect underlying hepatic dysfunction rather than the severity or prognosis of gastrointestinal bleeding itself.
Although the authors acknowledge hepatic dysfunction as a potential limitation of the B/A ratio, the prevalence of cirrhosis in the study population was not reported and its potential effect was not specifically assessed. This is particularly relevant because cirrhotic gastrointestinal bleeding represents a clinically distinct subgroup, frequently involving portal hypertensive and variceal bleeding.3 Pooling patients with and without cirrhosis may therefore confound the observed association between the B/A ratio and clinical outcomes.
This issue could be addressed within the existing cohort by reporting the prevalence of cirrhosis and performing stratified analyses according to cirrhosis status. Comparing the predictive performance of the B/A ratio in cirrhotic versus non-cirrhotic patients, including subgroup-specific receiver operating characteristic curves and area under the curve values, would clarify whether its prognostic discrimination is preserved in the presence of chronic hepatic dysfunction. Among patients with upper gastrointestinal bleeding, an additional analysis according to variceal versus non-variceal etiology would further determine whether bleeding mechanism modifies the performance of the ratio. If sufficient clinical data are available, stratification according to hepatic dysfunction, such as Child–Pugh class or MELD score, could also help distinguish the contribution of impaired hepatic reserve from that of the acute bleeding event.
These analyses would help determine whether the B/A ratio functions as a broadly applicable prognostic marker in gastrointestinal bleeding or whether its interpretation requires adjustment for underlying liver disease. Until such stratification is performed, caution may be warranted when applying a single B/A threshold to patients with cirrhosis.
References
- Olcay HO, Emektar E, Tokgöz ZH, et al. The diagnostic and prognostic value of BUN/albumin and BUN/creatinine ratios in patients with gastrointestinal bleeding presenting to the emergency department. Ann Clin Anal Med. 2025;16(11):827-832. doi:10.4328/acam.22643
- Trebicka J, Garcia-Tsao G. Controversies regarding albumin therapy in cirrhosis. Hepatology. 2025;81(1):288-303. doi:10.1097/hep.0000000000000521
- Diaz-Soto MP, Garcia-Tsao G. Management of varices and variceal hemorrhage in liver cirrhosis: a recent update. Ther Adv Gastroenterol. 2022;15:17562848221101712. doi:10.1177/17562848221101712
Additional Information
Publisher’s Note
Bayrakol MP remains neutral with regard to jurisdictional and institutional claims.
Rights and Permissions
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
About This Article
How to Cite This Article
Ali Karataş. Comment on: interpretation of the BUN/albumin ratio in gastrointestinal bleeding (the impact of cirrhosis). Ann Clin Anal Med 2026;18(2):00-00. doi:10.4328/ACAM.50219
Publication History
- Received:
- 31.05.2026
- Accepted:
- 11.09.2026
- Published Online:
- 11.09.2026